Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0313830 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Abhijit Debnath und 3 weiteren Autor:innen. Beteiligte Einrichtung: Noida Institute of Engineering and Technology [Pharmacy Institute], Institutional Area, Greater Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Biological Products, Protein Kinase Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health Research, India.
Abstract (Originalsprache)
Cyclin-dependent kinases 4 and 6 (CDK4/6) are crucial regulators of cell cycle progression and represent important therapeutic targets in breast cancer. This study employs a comprehensive computational approach to identify novel CDK4/6 inhibitors from marine natural products. We utilized structure-based virtual screening of the CMNPD database and MNP library, followed by rigorous filtering based on drug-likeness criteria, PAINS filter, ADME properties, and toxicity profiles. From an initial hit of 9,497 compounds, 2,344 passed drug-likeness and PAINS filters. Further ADME filtering yielded 50 compounds, of which 25 exhibited non-toxic profiles. These 25 candidates underwent consensus molecular docking using seven distinct algorithms: AutoDockTools 4.2, idock, LeDock, Qvina 2, Smina, AutoDock Vina 1.2.0, PLANTS, and rDock. Based on these results, six top-scoring compounds were selected for comprehensive 500 nanosecond all-atom molecular dynamics simulations to evaluate their structural stability and interactions with CDK4/6. Our analysis revealed that compounds CMNPD11585 and CMNPD2744 demonstrated superior stability in their interactions with CDK4/6, exhibiting lower RMSD and RMSF values, more favorable binding free energies, and persistent hydrogen bonding patterns. These compounds also showed lower Solvent Accessible Surface Area values, indicating better compatibility with the CDK4/6 active site. Subsequent in-vitro studies using MTT assays on MCF-7 breast cancer cells confirmed the cytotoxic effects of these compounds, with CMNPD11585 showing the highest potency, followed by CMNPD2744.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Noida Institute of Engineering and Technology [Pharmacy Institute], Institutional Area, Greater Noida, Uttar Pradesh, India.
- Department of Dravyaguna, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
ORCID-Profile: Abhijit Debnath
Förderung
- Department of Health Research, India
Zitieren
APA
Debnath, A., Mazumder, R., Singh, A. K., & Singh, R. K. (2025). Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products. PLOS ONE. https://doi.org/10.1371/journal.pone.0313830
Vancouver
Debnath A, Mazumder R, Singh AK, Singh RK. Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products. PLOS ONE. 2025. doi:10.1371/journal.pone.0313830
BibTeX
@article{Debnath2025,
author = {Debnath, Abhijit and Mazumder, Rupa and Singh, Anil Kumar and Singh, Rajesh Kumar},
title = {Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0313830}
}
EUVIMED